95018 is for drug or biologic allergy testing; 95017 is used for venom testing.
On this page
CMS RVU26D · Effective 2026-10-01
95018 Drug allergy testing Medicare reimbursement rates in Kentucky
Reports immediate-reaction skin testing for suspected drug or biologic allergy using percutaneous and/or intracutaneous methods, with interpretation and a report. Compare 95018 office and facility rates across CMS payment localities in Kentucky.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 95018 in Kentucky?
Kentucky has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$17.45
1 of 1 localities have a supported rate.
Payment area: Kentucky
One mapped payment locality.
Facility setting
$5.87
1 of 1 localities have a supported rate.
Payment area: Kentucky
One mapped payment locality.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Allergy testing
About 95018: Drug and biologic allergy skin testing
Reports immediate-reaction skin testing for suspected drug or biologic allergy using percutaneous and/or intracutaneous methods, with interpretation and a report.
An allergist or other qualified clinician uses percutaneous and/or intracutaneous testing to evaluate a suspected immediate hypersensitivity reaction to a drug or biological product. Testing may be considered when a medication allergy history needs clinical evaluation, such as before deciding whether a patient can receive a needed antibiotic. The code covers a combination of the two skin-test methods; it is specific to drugs and biologicals rather than environmental allergen extracts.
Report the number of tests performed, and retain documentation identifying the agents and test methods, the results, and the clinician’s interpretation and report. Interpretation and reporting are part of the service, rather than separate services for the same tests. Under the Medicare Physician Fee Schedule, payment is based on work, practice expense, and malpractice relative value units; the practice-expense valuation differs between office and facility settings. The supplied CMS rules list no code-specific payment adjustments.
Where the value comes from
- Work RVU0.14 · 25%
- Practice expense (office) RVU0.42 · 74%
- Malpractice RVU0.01 · 2%
87.9K
Medicare services in 2024 · #602 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
95018 compared with similar codes
Office rates for Kentucky, from the same CMS release.
95004 describes percutaneous tests with allergenic extracts. Choose 95018 when testing drugs or biologicals, including when percutaneous testing is part of a combination of methods.
95024 is for intracutaneous tests with allergenic extracts. 95018 covers drug or biologic testing using intracutaneous testing alone or with percutaneous testing.
Compare 95018 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Kentucky →
Office / nonfacility
$17.45
Facility
$5.87
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 95018 in Kentucky.
PPRRVU2026_Oct_nonQPP.csv
12,460
- Code
- 95018
- Physician work
- 0.14
- Practice expense
- 0.42
- Malpractice
- 0.01
GPCI2026.csv
55
- Locality
- Kentucky
- Physician work
- 1.000
- Practice expense
- 0.889
- Malpractice
- 0.915
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.14 | × 1.000 | 0.1400 |
| Practice expense | 0.42 | × 0.889 | 0.3734 |
| Malpractice | 0.01 | × 0.915 | 0.0092 |
| Total RVUs | 0.5225 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Kentucky$17.45
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.14 | 1 |
| Practice expense | 0.42 | 0.889 |
| Malpractice | 0.01 | 0.915 |
(0.14 × 1 + 0.42 × 0.889 + 0.01 × 0.915) × $33.4009 = $17.45
Facility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.14 | 1 |
| Practice expense | 0.03 | 0.889 |
| Malpractice | 0.01 | 0.915 |
(0.14 × 1 + 0.03 × 0.889 + 0.01 × 0.915) × $33.4009 = $5.87
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
95018 billing questions
When should 95018 be chosen over 95017?
Use 95018 for drug or biological products. Code 95017 is the related testing code for venom allergy testing.
Can percutaneous and intracutaneous methods be reported together under 95018?
Yes. The code covers any combination of these methods for drug or biologic testing; report the number of tests performed.
Is interpretation separately billable?
Test interpretation and the report are included in 95018. Document the results and the clinician’s interpretation in the record.
What documentation supports the number of tests?
Record the drug or biological agents tested, the methods used, and the individual test results. The reported number should reflect the tests actually performed.
Is 95018 for environmental allergen testing?
No. It is for immediate-reaction testing with drugs or biologicals. Testing with allergenic extracts is represented by other allergy-testing codes, such as 95004 or 95024.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
